2020PubMed@AikoHIRAKI:32376603 JSONTXT

Annnotations TAB JSON ListView MergeView

Covid19_manual_annotation

Id Subject Object Predicate Lexical cue ForCovid19 tao:has_database_id
T1 101-109 Disease denotes COVID-19 MESH:C000657245
T10 701-711 Species denotes SARS-CoV-2 Tax:2697049
T11 780-790 Species denotes SARS-CoV-2 Tax:2697049
T12 1073-1083 Species denotes SARS-CoV-2 Tax:2697049
T13 130-177 Species denotes severe acute respiratory syndrome-coronavirus 2 Tax:2697049
T14 36-43 Chemical denotes vaccine drug
T15 303-311 Chemical denotes vaccines drug
T16 393-401 Chemical denotes vaccines drug
T17 528-535 Chemical denotes vaccine drug
T18 1084-1092 Chemical denotes vaccines drug
T19 111-119 Pandemic denotes pandemic MESH:D058873
T2 75-99 Disease denotes coronavirus disease 2019 MESH:C000657245
T20 333-353 Species denotes novelty of the virus Tax:2697049
T21 499-510 Type denotes inactivated
T22 24-35 Type denotes inactivated
T23 547-555 Chemical denotes PiCoVacc drug
T24 619-623 Species denotes mice Tax:10090
T25 625-629 Species denotes rats Tax:10116
T26 634-652 Species denotes non-human primates
T27 564-571 Induce denotes induced
T28 592-615 Biological denotes neutralizing antibodies MESH:D057134
T29 847-851 Amount denotes 3 μg
T3 930-940 Species denotes SARS-CoV-2 Tax:2697049
T30 855-859 Amount denotes 6 μg
T31 913-921 Species denotes macaques Tax:9539
T32 1019-1028 Disease denotes infection MESH:D007239
T33 1004-1015 PositiveRegulation denotes enhancement
T34 966-973 NegativeRegulation denotes without
T35 899-909 Interrupt denotes protection
T36 879-886 Condition denotes partial
T37 890-898 Condition denotes complete
T38 899-909 Interrupt denotes protection
T39 800-819 Times denotes Three immunizations
T4 58-68 Species denotes SARS-CoV-2 Tax:2697049
T40 840-845 Dose denotes doses
T41 840-845 Dose denotes doses
T42 683-700 Kinds denotes 10 representative
T43 712-719 Kinds denotes strains
T44 671-682 Interrupt denotes neutralized
T45 654-670 Biological denotes These antibodies
T5 179-189 Species denotes SARS-CoV-2 Tax:2697049
T6 269-279 Species denotes SARS-CoV-2 Tax:2697049
T7 410-420 Species denotes SARS-CoV-2 Tax:2697049
T8 511-521 Species denotes SARS-CoV-2 Tax:2697049
T9 572-582 Species denotes SARS-CoV-2 Tax:2697049
R1 T1 T2 abbreviation COVID-19,coronavirus disease 2019
R11 T17 T21 of_a vaccine,inactivated
R12 T14 T22 of_a vaccine,inactivated
R13 T23 T17 named PiCoVacc,vaccine
R14 T17 T27 is_a vaccine,induced
R15 T27 T28 is_a induced,neutralizing antibodies
R16 T9 T28 against SARS-CoV-2,neutralizing antibodies
R17 T24 T28 in mice,neutralizing antibodies
R18 T25 T28 in rats,neutralizing antibodies
R19 T26 T28 in non-human primates,neutralizing antibodies
R2 T5 T13 abbreviation SARS-CoV-2,severe acute respiratory syndrome-coronavirus 2
R31 T3 T38 against SARS-CoV-2,protection
R32 T34 T33 is_a without,enhancement
R33 T33 T32 is_a enhancement,infection
R34 T34 T38 of_a without,protection
R35 T34 T35 of_a without,protection
R36 T42 T43 - 10 representative,strains
R37 T45 T28 coreference These antibodies,neutralizing antibodies
R20 T29 T40 of_a 3 μg,doses
R21 T30 T41 of_a 6 μg,doses
R22 T39 T40 of_a Three immunizations,doses
R23 T39 T41 of_a Three immunizations,doses
R24 T40 T35 is_a doses,protection
R25 T3 T35 against SARS-CoV-2,protection
R26 T31 T40 of_a macaques,doses
R27 T31 T41 of_a macaques,doses
R28 T35 T36 has_status protection,partial
R29 T38 T37 has_status protection,complete
R3 T20 T6 coreference novelty of the virus,SARS-CoV-2
R30 T41 T38 is_a doses,protection
R38 T45 T44 of_a These antibodies,neutralized
R39 T10 T44 to SARS-CoV-2,neutralized
R4 T13 T19 cause_of severe acute respiratory syndrome-coronavirus 2,pandemic
R40 T10 T42 of_a SARS-CoV-2,10 representative
R5 T13 T2 cause_of severe acute respiratory syndrome-coronavirus 2,coronavirus disease 2019
R6 T4 T14 against SARS-CoV-2,vaccine
R7 T7 T16 against SARS-CoV-2,vaccines
R8 T8 T17 against SARS-CoV-2,vaccine